Premium
O2‐13‐02: Humanized Mab, Armanezumab Targeting N‐Terminus of Pathological Tau: Characterization and Therapeutic Potency
Author(s) -
Ghochikyan Anahit,
Zagorski Karen,
Kazarian Konstantin,
Davtyan Hayk,
Petrushina Irina,
Davis Joy,
Chen Wesley W.,
Antonenko Maxim,
Blurton-Jones Mathew,
Cribbs David H.,
Agadjanyan Michael G.
Publication year - 2016
Publication title -
alzheimer's and dementia
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 6.713
H-Index - 118
eISSN - 1552-5279
pISSN - 1552-5260
DOI - 10.1016/j.jalz.2016.06.467
Subject(s) - monoclonal antibody , humanized antibody , epitope , tauopathy , biology , in vivo , microbiology and biotechnology , epitope mapping , antibody , chemistry , immunology , medicine , neurodegeneration , pathology , genetics , disease
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom